David Chung

Title: Innovations of David Chung in Gonadal Peptides

Introduction

David Chung is an accomplished inventor based in Castro Valley, California. He has made significant contributions to the field of biochemistry, particularly in the study of gonadal peptides. His work has led to the development of novel peptides that exhibit inhibin-like activity, which are crucial for understanding reproductive biology.

Latest Patents

David Chung holds a patent for his invention titled "Human seminal alpha-inhibins." This patent discloses novel gonadal peptides, specifically two peptides consisting of 52 and 92 amino acids, respectively. These peptides were initially isolated from human seminal plasma and have since been chemically synthesized. The peptides are designated as alpha-inhibin-52 and alpha-inhibin-92. Sequence analyses reveal that the NH.sub.2-terminal 31 amino acids of alpha-inhibin-52 are identical to a previously reported inhibin-like peptide. Additionally, the COOH-terminal 52 amino acids of alpha-inhibin-92 are identical to those of alpha-inhibin-52.

Career Highlights

David Chung is affiliated with the University of California, where he conducts his research and development work. His innovative approach to studying gonadal peptides has positioned him as a notable figure in his field. With a patent count of 1 patent, he continues to contribute to scientific advancements.

Collaborations

David Chung has collaborated with esteemed colleagues such as Kristipati Ramasharma and Choh Hao Li. Their combined expertise has furthered the understanding of inhibin-like peptides and their potential applications.

Conclusion

David Chung's work in the field of gonadal peptides represents a significant advancement in biochemistry. His patented innovations have the potential to impact reproductive health and biology.